{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00118",
      "entity_text" : "IgG1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00744",
      "entity_text" : "pVAX-IL-33",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Co-administration of pVAX-IL-33 with pVAX-ROP5 + pVAX-ROP18 induced the highest IgG2a / IgG1 ratio.",
  "reading_complete" : "2020-08-03T11:55:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:51:35Z",
  "trigger" : "induced",
  "evidence" : [ "pVAX-IL-33 with pVAX-ROP5 + pVAX-ROP18 induced the highest IgG2a/IgG1" ],
  "pmc_id" : "7174000",
  "score" : 0
}